Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Census population 176,654. Oregon Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Eugene clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Eugene storefront.
Growth Factor Therapy for Tissue Repair in Eugene, OR for clinics & physicians. Growth factor therapy prod… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Obesity 34%; arthritis 26%. Those three PLACES crude rates (plus Census 176,654) are the local facts on this page. Everything else is the national growth factor therapy catalog and JF paperwork.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)8.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 176,654 residents will still mix those payers. CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 9.4% of adults in Eugene have diagnosed diabetes — 2.6 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the growth factor therapy account.
CDC PLACES (2023, crude prevalence) estimates 9.4% of adults — 2.6 points below the U.S. 12% figure. Obesity is 34%; arthritis is 26%. That is place-level BRFSS modeling, not a clinic census and not a Eugene trial.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
Oregon is in CMS MAC JF, administered by Noridian Healthcare Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay.
Bring specialty, monthly joint / regenerative volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.4% diabetes and 26% arthritis for Eugene — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Eugene, OR.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Eugene is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Eugene — 2.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Oregon Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Eugene. Useful for joint-program math; still needs a diagnosis and privileging.
No Eugene storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.